UCR's monitors are experienced in monitoring clinical trials and have covered a large number of differing therapy areas.

Monitoring planning is based on current regulatory requirements and guidelines in accordance with the International Conference of Harmonization – Good Clinical Practice (ICH-GCP) and statutes from the Medical Products Agency (LVFS 2011:19).

We have developed a work process specifically for risk-based monitoring, but we can also offer more traditional monitoring with monitoring visits before, during and after the study.

Back to top